We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

215 hedge funds and large institutions have $1.15B invested in Editas Medicine in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 56 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 25

49% more call options, than puts

Call options by funds: $40.4M | Put options by funds: $27.1M

30% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 56

11% more capital invested

Capital invested by funds: $1.03B → $1.15B (+$119M)

9% more funds holding

Funds holding: 197 → 215 (+18)

1.62% more ownership

Funds ownership: 66.44% → 68.05% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
215
Holders Change
+18
Holders Change %
+9.14%
% of All Funds
4.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
46
Increased
73
Reduced
56
Closed
25
Calls
$40.4M
Puts
$27.1M
Net Calls
+$13.2M
Net Calls Change
+$651K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$20.2M
3
AIM
ARK Investment Management
Florida
+$19.9M
4
State Street
State Street
Massachusetts
+$7.14M
5
Morgan Stanley
Morgan Stanley
New York
+$6.59M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$40.7M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$12.1M
3
Millennium Management
Millennium Management
New York
-$10.3M
4
TCIM
TIAA CREF Investment Management
New York
-$7.37M
5
American Century Companies
American Century Companies
Missouri
-$6.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
KJWM
176
Kiley Juergens Wealth Management
Washington
$17K +$17.7K +500 New
APA
177
American Portfolios Advisors
New York
$16.1K +$14.2K +400 +800%
ZB
178
Zions Bancorporation
Utah
$14K – – –
S
179
SignatureFD
Georgia
$14K +$3.54K +100 +33%
Macquarie Group
180
Macquarie Group
Australia
$14K +$14.2K +400 New
GWS
181
Glassman Wealth Services
Virginia
$12K – – –
WEC
182
Winslow Evans & Crocker
Massachusetts
$12K – – –
CIBC Private Wealth Group
183
CIBC Private Wealth Group
Georgia
$11K -$35 -1 -0.3%
WT
184
Whittier Trust
California
$11K +$10.6K +298 New
Parallax Volatility Advisers
185
Parallax Volatility Advisers
California
$11K +$11.2K +315 New
RCAG
186
Rehmann Capital Advisory Group
Michigan
$10.7K -$164K -4,633 -94%
TCM
187
Tradewinds Capital Management
Washington
$10K – – –
CWM
188
Catamount Wealth Management
Connecticut
$9K -$5.31K -150 -33%
MYIA
189
Mount Yale Investment Advisors
Colorado
$9K – – –
Daiwa Securities Group
190
Daiwa Securities Group
Japan
$8K – – –
MAM
191
Meeder Asset Management
Ohio
$7.06K +$2.83K +80 +68%
CFD
192
Creative Financial Designs
Indiana
$7K – – –
SIA
193
SeaBridge Investment Advisors
New Jersey
$7K – – –
WAP
194
Wealthcare Advisory Partners
Pennsylvania
$7K +$4.96K +140 +215%
WCAMG
195
Woodard & Company Asset Management Group
North Carolina
$5.38K – – –
CCM
196
Cribstone Capital Management
Maine
$5K – – –
IGGA
197
Iron Gate Global Advisors
Utah
$5K +$4.78K +135 New
AF
198
Advisornet Financial
Minnesota
$5K +$5.31K +150 New
GFP
199
Gryphon Financial Partners
Ohio
$4K – – –
GC
200
Grace Capital
Massachusetts
$4K +$3.93K +111 New
6 7
8
9 10

EDIT Hedge Fund Activity: Q2 2018 in Review

215 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2018, worth a combined $1.15B — up 11% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new EDIT positions and 25 closed out — a net gain of 21 holders — while 73 added to existing stakes and 56 trimmed.

The largest buyer was BlackRock, adding an estimated $20.9M. The largest seller was Fidelity Investments, cutting an estimated $40.7M.

  • 215 institutional investors held Editas Medicine (EDIT) as of Q2 2018, up from 197 in Q1 2018.
  • Funds reported $1.15B of Editas Medicine stock for Q2 2018, up 11% quarter-over-quarter.
  • 46 funds opened new Editas Medicine positions in Q2 2018 and 25 closed out, a net change of +21 holders.
  • The largest Editas Medicine buyer in Q2 2018 was BlackRock, an estimated $20.9M added.
  • The largest Editas Medicine seller in Q2 2018 was Fidelity Investments, an estimated $40.7M sold.

Based on aggregated 13F filings for Q2 2018.